Mike Lambert

Chief Financial Officer

Portrait of Mike Lambert, Chief Financial Officer

Mike Lambert joined Designs for Health as Chief Financial Officer in 2022. In this role, he directs the organization's strategic planning, financial analysis and modeling, treasury and tax management, accounting, internal controls, and financial reporting. Mike brings over 30 years of finance and accounting experience to Designs for Health, including 15 years of financial leadership in high-growth life science businesses. Prior to joining DFH, Mike led the financial organization for Deerland Probiotics and Enzymes, a specialty manufacturer of science-backed supplement solutions using probiotic, prebiotic, and enzyme technology.

Designs for Health

Terms & Conditions

For media/press inquiries, please contact press@designsforhealth.com.

* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

©2019-2026 Designs for Health, Inc. All rights reserved.

The Designs for Health Spotlight™ functional wellness tests are not diagnostic and are not eligible for coverage under Medicare, Medicaid, or medical insurance. DFH Spotlight testing must be ordered or authorized by a qualified health-care provider registered with DFH. Please reach out directly to your practitioner to express your interest in any of the Spotlight tests. Spotlight test kits are not available for purchase or shipping in New York or the U.S. territories.

††U.S.A. Functional Medicine MDs, DOs, NDs, DCs, and Nutrition Professionals surveyed in 2025 for Designs for Health.

¹Sawada D, Kawai T, Nishida K, Kuwano Y, Fujiwara S, Rokutan K. Daily intake of Lactobacillus gasseri CP2305 improves mental, physical, and sleep quality among Japanese medical students enrolled in a cadaver dissection course. J Funct Foods. 2017;31:188-197. doi:10.1016/j.jff.2017.01.042.

²Keystone commensal strains based on the HACK index. 8x comparison based on five keystone strains (up to 24% combined abundance) vs. single-strain Akkermansia  products (~3%). Percentages reflect typical abundance in healthy adult microbiomes per published research. Individual colonization varies.